Menu UF Health Home Menu
 

Award History

In 2010-2011 departmental Primary Investigators received multiple new awards totaling $13,535,989.28. These awards for basic science projects, clinical trials and community outreach initiatives are supported by agencies including NIH, Health Resources and Human Development, Department of Education, Department of Defense, American Heart Association, Partnership for Strong Families, United Way, DOH, Cystic Fibrosis Foundation, Jaeb Center for Health Research, Alex’s Lemonade Stand, Bayer Group, Children’s Fund for Glycogen Storage Disease Research , Agency for Healthcare Research and Quality, Juvenile Diabetes Foundation and March of Dimes.

Below is a list of active awards for the Department of Pediatrics faculty.

New awards since July 1, 2011

Principal Investigator Funding Agency Title
ABU HASAN M N MPEX PHARMACEUTICALS MPEX-209:  …MP-376 INHALATION SOLUTION (AEROQUIN) VERSUS  TOBRAMYCIN INHALATION SOLUTION (TIS) IN STABLE CF PATIENTS
BYRNE B J UNIV OF PENNSYLVANIA FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES:             INFLAMMATION, FIBROSIS AND FAT
CONLON T J NATL TAIWAN UNIV HOSPITAL PRECLINCIAL STUDY OF ADEN ASSOCIATED VIRUS MEDIATED GENE    THERAPY FOR AROMATIC L-AMINO ACID DECARBOXYLASE (AADC)….
CONLON T J UNIV OF PENNSYLVANIA CLINICAL TRIALS OF GENE THERAPY FOR LEBER CONGENITAL        AMAUROSIS
DHARNIDHARKA V R MCGILL UNIVERSITY TAKE IT:  TEEN ADHERENCE IN KIDNEY TRANSPLANT EFFECTIVENESS OF INTERVENTION TRIAL
DRISCOLL D J PRADER-WILLI SYNDROME ASSO HORMONAL ANALYSIS OF DEVELOPMENT OF OBESITY AND HYPERPHA FELLOWSHIP
ESERNIO-JENSSEN D FL DEPT OF LEGAL AFFAIRS VOCA CHILD PROTECTION TEAM
FILLIPPS D J UF MEDICAL GUILD REACH OUT AND READ
GARIN E H UNIV OF COLORADO CD80 EXPRESSION ON PODOCYTES AND THE PATHOGENESIS OF MINIMALCHANGE DISEASE
HALLER M J JUVENILE DIABETES FOU NANOPARTICLE-COUPLED TREGS FOR THE TERATEMENT OF TYPE 1 DIABETES
HERZOG R NATL INST OF HLTH ORAL THERAPY FOR HEMOPHILIA A
HERZOG R UNIV OF CENTRAL FLORIDA ORAL IMMUNE MODULATORY THERAPY USING ANTIGENS               BIOENCAPSULATED IN PLANT CELLS
HOFFMAN B E PFIZER INC TLR-9 SIGNALING AND IMMUNE TOLERANCE MODULATION DURING AAV  FACTOR IX GENE THERAPY FOR HEMOPHILIA B
NEU J GERBER FOUNDATION EFFECTS OF NOT MEASURING GASTRIC RESIDUALS PRIOR TO ENTERAL BOLUS FEEDING ON GASTROINTESTINAL FUNCTION AND FEEDING TOLER
SCHATZ D A JAEB CTR FOR HLTH RES PEDIATRIC DIABETES CONSORTIIUM – REGISTRY PHASE 2
SILVERSTEIN J H SANOFI AVENTIS COMPARISON OF EFFECTIVENESS OF GLULISISNE AND LISPRO IN     DECREASING POST-PRANDIAL HYPERGLYCEMIA IN A REAL-WORLD . . .
THOMPSON L A FL HEALTHY KIDS CORP EVALUATION OF FLORIDA HEALTH KIDS
TULI S Y KIDS CENTRAL CAPP PROGRAM DISTRICT XIII
TULI S Y PARTNERSHIP FOR STRONG FAM CAPP NURTURING PROGRAM (DISTRICT III)
WARNER T D NATL INST OF HLTH BRAIN DEVELOPMENT, BEHAVIOR AND COGNITION IN PRE- AND POSTNATAL COCAINE EXPOSURE

Ongoing projects active as of July 1, 2011

Principal Investigator Funding Agency Title
ARAYA C E CHILDREN’S MERCY HOSPITAL INTERNATIONAL PEDIATRIC PERITONEAL DIALYSIS NETWORK REGISTRY(IPPN)
ASLANIDI G V AMER CANCER SOC DEVELOPMENT OF RECOMBINANAT ADENO-ASSOCIATED VIRUS VECTORS FOR THE POTENTIAL TREATMENT OF LIVER CANCER
AYOUB E M YALE UNIVERSITY PEDIATRIC INFECTIOUS DISEASES AND RHEUMATOLOGY
BLACK E W US DEPT OF EDUCATION ONLINE MEDICAL EDUCATION DEGREE (ONMED): ANDRAGOGIC SKILLS  FOR 21ST CENTURY
BLEIWEIS M S BERLIN HEART EMERGENCY/COMPASSIONATE USE DATA COLLECTION AGREEMENT –     BERLIN HEART EXCOR PEDIATRIC VAD SYSTEM
BREITINGER P UNIV OF TEXAS FOCUS: RDMZ, CONT, PHASE II, DBLE-BLND TRIAL OF INTRAMYOCARDIAL INJECTION OF AUTOLOGOUS BONE MARROW MONOUCLEAR CELLS UND
BURCHFIELD D J BIOSYNEXUS A PHASE 2B/3, MULTI-CENTER RNDMZ, DBL-BLD, PLACEBO CONTROLLED TRIAL TO EVALUATE THE SAFETY & EFFICACY OF PAGIBAXIMAB INJ
BURCHFIELD D J DUKE UNIV FLUCONAZOLE PROPHYLAXIS FOR THE PREVENTION OF CANDIDIASIS ININFANTS <750 GRAMS BIRTH WEIGHT
BURCHFIELD D J MARCH OF DIMES NICU FAMILY SUPPORT SPECIALIST
BYRNE B J BARTH SYNDROME FOU GENE THERAPY IN MOUSE MODEL OF BARTH SYNDROME
BYRNE B J BIOMARIN PHARMACEUTICAL PHASE 1 OPEN LABEL SAFETY/TOLERABILITY/PK/PD STUDY OF ZC-701 (GILT-TAGGED RECOMBINANT HUMAN GAA) IN PATIENTS WITH LATE–
BYRNE B J GENZYME CORP A LONG TERM STUDY TO EVALUATE GROWTH AND DEVELOPMENT OUTCOMES IN PATIENTS WITH INFANTILE ONSET POMPE DISEASE WHO ARE….
BYRNE B J  GENZYME CORP ALGLUCOSIDASE ALFA TEMPORARY ACCESS PROGRAM
BYRNE B J  GENZYME CORP DATA REGISTRY SERVICES-
BYRNE B J  GENZYME CORP ENZYME ACTIVITY AND CRIM STATUS IN PATIENTS WITH LATE-ONSET POMPE DISEASE WHO  HAVE NEVER RECEIVED ENZYME REPLACEMENT…
BYRNE B J  GENZYME CORP PHS 4…STUDY IN PATIENTS WITH LATE-ONSET POMPE DISEASE     TREATED WITH ALGLUCOSIDASE ALFA (PROTOCOL AGLU07310)
BYRNE B J MUSCULAR DYSTROPHY ASSO CLINICAL TRIAL SUPPORT FOR MUSCULAR DYSTROPHY STUDIES
BYRNE B J  MUSCULAR DYSTROPHY ASSO MRI ASSESSMENT OF PTC124 TREATMENT IN BOYS WITH DMD         (MDA135557)
BYRNE B J NATL INST OF HLTH GENE THERAPY FOR CARDIAC AND SKELETAL MYOPATHIES
BYRNE B J  NATL INST OF HLTH MAGNETIC RESONANCE IMAGING AND BIOMARKERS FOR MUSCULAR DYSTROPHY
BYRNE B J  NATL INST OF HLTH MR MONITORING OF PTC124 TREATMENT IN DMD
BYRNE B J  NATL INST OF HLTH PROJ 4: TRANSDUCTION OF HEPATOCYTES WITH RECOMBINANT        AAV FOR TION OF GENETIC AND METABOLIC ABNORMALITIES
BYRNE B J  NATL INST OF HLTH PROJECT 3: “CORRECTION OF INHERITED CARDIOMYOPATHY USING    AAV VECTORS”
BYRNE B J  NATL INST OF HLTH RECOMBINANT AAV FOR TION OF GENETIC AND METABOLIC           ABNORMALITIES-CORE B-VECTOR CORE
BYRNE B J NATL INSTITUTES OF HEALTH UFCC FOR CARDIOVASCULAR CELL THERAPY RESEARCH NETWORK
BYRNE B J SOCIAL AND SCIENTIFIC SYSTEMS PHASE I/II TRIAL OF DIAPHRAGM DELIVERY OF RECOMBINANT       AAV1-CMV-GAA GENE VECTOR IN PATIENTS WITH POMPE DISEASE
BYRNE B J UF RESEARCH FOU MISC GENE THERAPY CENTER
BYRNE B J UNIV OF PENNSYLVANIA CLINICAL TRIALS OF GENE THERAPY FOR LEBER CONGENITAL AMAUROSIS ( MODULE 1)
BYRNE B J  UNIV OF PENNSYLVANIA CLINICAL TRIALS OF GENE THERAPY FOR LEBER CONGENITAL AMAUROSIS ( MODULE II)
BYRNE B J  UNIV OF PENNSYLVANIA FAILED REGENERATION IN THE MUSCULAR DYSTROPHIES:             INFLAMMATION, FIBROSIS AND FAT
BYRNE B J ZYSTOR THERAPEUTICS INC GILT TAGGED ENZYME REPLACEMENT THERAPY FOR POMPE DISEASE
CAO O AMER HEART ASSO FL INDUCTION OF TOLERANCE TO THERAPEUTIC PROTEINS THROUGH      SPECIFIC ROUTES OF ANTIGEN ADMINISTRATION
CAO O NATL INST OF HLTH TAILORING AAV VECTORS FOR GLIOMA IMMUNOTHERAPY
CARNEY P R CYBERONICS INC 3-DIMENSIONAL ACCELEROMETER SUB-STUDY FOR PATIENTS          PARTICIPATING IN THE E-30 STUDY: HEART RATE CHANGES IN . .
CARNEY P R  CYBERONICS INC HEART RATE CHANGES IN SUBJECTS WITH EPILEPSY DURING AN      EPILEPSY MONITORING UNIT ADMISSION
CARNEY P R NATL INST OF HLTH COMPUTATIONAL TRANSPORT MODELS FOR CONVECTION-ENHANCED CNS DELIVERY
CARNEY P R  NATL INST OF HLTH NONINVASIVE FUNCTIONAL AND CELLULAR IMAGING OF EPILEPSY
CARNEY P R US ARMY PHOTOACOUSTIC IMAGING OF EPILEPSY
CLEAVER B D APPLIED GENETICS TECH CORP STABILITY TESTING PRODUCT STORAGE AND REGULATORY            SUPPORT OF RAAV2-CB-HRPE
CLEMENT N UNIV OF MIAMI SERVICE AGREEMENT…FOR THE DEVELOPMENT, MANUFACTURING, AND TESTING OF SCAAV2(Y444,500,730F)-SM CBA-PIND4
CONLON T J CHILDREN’S FUND GLYCO STOR DIS GENE THERAPY FOR GLYCOGEN STORAGE DISEASE TYPE 1A
DHARNIDHARKA V R ABBOTT LABORATORIES A PROSPECTIVE, MULTICENTER STUDY TO EVALUATE THE SAFETY OF VITAMIN D RECEPTOR ACTIVATORS AS DETERMINED BY HYPERCACEMIA
DHARNIDHARKA V R AMGEN INC A MULTICENTER DOUBLE BLIND RANDOMIZED STUDY EVALUATING DE NOVO WEEKLY AND ONCE EVERY 2 WEEK DARBEPOETIN ALFA DOSING…..
DHARNIDHARKA V R  AMGEN INC A RANDOMIZED, D/B, PLACEBO-CONTROLLED STUDY TO ASSESS THE   EFFICACY & SAFETY OF CINACALCET HCL IN PEDIATRIC SUBJECTS…
DHARNIDHARKA V R CHILDREN’S HOSP BOSTON NOVEL THERAPIES FOR CHRONIC ALLOGRAFT DYSFUNCTION IN CHILDREN
DHARNIDHARKA V R CHILDRENS HOSP PHILADELPHIA CHRONIC KIDNEY DISEASE IN CHILDREN (CKID)
DHARNIDHARKA V R EMMES CORP A RNDMZD MULTI-CTR COMPARATIVE TRIAL OF                     TACROLIMUS WITH STER OIDS &   STANDARD DACLIZUMAB INDUCTION
DHARNIDHARKA V R  EMMES CORP NORTH AMERICAN PEDIATRICS RENAL TRANSPLANT COOPERATIVE STUDY
DHARNIDHARKA V R WASHINGTON UNIV VIRAL TRIGGERS OF ALLOIMMUNITY AND AUTOIMMUNITY IN PEDIATRICLUNG TRANSPLANTATION/PERCEIVED BARRIERS TO PATIENT ADHERENCE
DRISCOLL D J CA STATE UNIVERSITY FULLERTON PRADER-WILLI RESEARCH PROGRAM: PROJ 2: NUTRITIONAL ASPECTS  OF WILLI SYNDROME AND CHILDHOOD OBESITY
DRISCOLL D J CSU FULLERTON AUX SERV CORP NUTRITIONAL ASPECTS OF PRADER-WILLI SYNDROME AND CHILDHOOD OBESITY
DRISCOLL D J HAYWARD FOU, JOHN & WINIFRED HAYWARD FOUNDATION GRANT
DRISCOLL D J SCHILLER FOUNDATION SCHILLER FOUNDATION GRANT
DRISCOLL D J UNIV OF ALABAMA RARE DISEASE CRC FOR NEW THERAPIES AND NEW DIAGNOSTICS
DUMONT-DRISCOLL M C CSU FULLERTON AUX SERV CORP FAMILY-BASED EXERCISE INTERVENTIONS FOR CHILDREN AND ADOLESCENTS WITH PRADER-WILLI SYNDROME
ESERNIO-JENSSEN D FL DEPT OF LEGAL AFFAIRS VOCA CHILD PROTECTION TEAM
ESERNIO-JENSSEN D GATOR EXCHANGE CLUB PREVENT CHILD ABUSE IN ALACHUA COUNTY
GONZALEZ R BRISTOL MYERS SQUIBB CO A COMPARATIVE STUDY OF THE ANTIVIRAL EFFICACY AND SAFETY OF ENTECAVIR (ETV) VERSUS PLACEBO IN PEDIATRIC SUBJECTS…….
GONZALEZ R BRISTOL MYERS SQUIBB CO EVAL OF PHARMACHOKINETICS, SAF/TOL/EFF OF ENTECAVIR (ETV) INPED SUBJ C CHRON HEP B VIRUS (HBV) INFECT WHO ARE HBEAG-POS
GONZALEZ R NOVARTIS US A CROSS SECTIONAL MULTICENTER EPIDEMIOLOGICAL STUDY IN WESTERN AND ASIAN COUNTRIES IN CHILDREN AND ADOLESCENTS WITH ….
HALLER M J GEORGIA HLTH SCIENCES UNIV CONSORTIUM FOR IDENTIFICATION OF ENVIRONMENTAL TRIGGERS –   SUBTITLED: TRIGGERS AND ENVIRONMENTAL DETERMINANTS . . .
HALLER M J JUVENILE DIABETES FOU NOVEL APPROACHES TO THE REVERSAL OF TYPE 1 DIABETES: SHORT COURUSE G-CSF AS IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES
HALLER M J OSIRIS THERAPEUTICS INC A PHASE II MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-     CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY……
HERZOG R NATL INST OF HLTH IMMUNOLOGY OF FACTOR IX GENE TRANSFER TO LIVER
HERZOG R NATL INST OF HLTH NEXT GENERATION OF RECOMBINANT AAV SEROTYPE VECTORS FOR GENETHERAPY
HERZOG R NATL INST OF HLTH NOVEL AAV VECTORS FOR HEMOPHILIA GENE THERAPY
HERZOG R THE WISTAR INST IMMUNE RESPONSES TO AAV-MEDIATED FIX GENE TRANSFER: PROJ 3  PATHWAYS TOWARD IMMUNE TOLERANCE TO COAGULATION FACTORS
HERZOG R UNIV OF CENTRAL FLORIDA PREVENTION OF INHIBITORS BY ORAL DELIVERY OF COAGULATION    FACTORS
HUANG S GENENTECH INC AN EPIDEMIOLOGIC STUDY OF XOLAIR (OMALIZUMAB), EVALUATION   CLINICAL EFFECTIVENESS AND LONG TERM SAFETY IN PATIENTS…..
HURTADO M D UF MEDICAL GUILD AN ALTERNATIVE PATHWAY FOR SATIETY:  THE ROLE OF SALIVARY   PYY IN FOOD INTAKE
JOLLEY C D CENTOCOR A MULTICENTER, PROSPECTIVE, LONG-TERM, OBSERVATIONAL REGISTRY OF PEDIATRIC PATIENTS WITH INFLAMMAROTY BOWEL DISEASE
JOLLEY C D  CENTOCOR FELLOWSHIP GRANT
JOLLEY C D JANSSEN PHARMACEUTICAL INC A MULTICENTER, PROSPECTIVE, LONG-TERM, OBSERVATIONAL REGISTRY OF PEDIATRIC PATIENTS WITH INFLAMMAROTY BOWEL DISEASE
JOLLEY C D PROCTER AND GAMBLE COMPANY A RANDOMIZED DOUBLE-BLIND PARALLEL-GROUP STUDY TO ASSESS THESAFETY AND EFFICACY OF ASACOL (1.2 TO 4.8 G/DAY)……
JOLLEY C D STUDY TO ASSESS THE SAFETY AND EFFICACY OF ASACOL (CAMP III)
LAWRENCE R M UNIV OF SOUTH FLORIDA FLORIDA AIDS EDUCATION TRAINING CENTERS
MALASANOS T ELI LILLY AND CO GENETICS AND NEUROENDOCRINOLOGY OF SHORT STATURE            INTERNATIONAL STUDY, PROTOCOL B9R-EW-GDFC
MILLER J L AMER COL OF GASTROENTEROLOGY FUNCTIONAL MAGNETIC RESONANCE IMAGING ASSESSMENT OF APPETITEAFTER INITIATION OF METFORMIN:  A PILOT STUDY
NATL INST OF HLTH NEUROANATOMIC STUDIES IN PRADER-WILLI SYNDROME AND EARLY-ONSET OBESITY
MUIR D F US DEPT OF DEFENSE NERVE DEGENERATION AND REGENERATION ASSOCIATED WITH NF1     TUMORS
NACKASHI J A KIDS CENTRAL CAPP PROGRAM DISTRICT XIII
NACKASHI J A PARTNERSHIP FOR STRONG FAM CAPP NURTURING PROGRAM (DISTRICT III)
NACKASHI J A UNITED WAY OF N CENTRAL FL SUCCESS BY SIX (SB6) NUTURING PROGRAM
NACKASHI J A  UNITED WAY OF N CENTRAL FL THE NURTURING PROGRAM OF THE CHILD ABUSE PREVENTION PROJECT (CAPP)
NEU J NATL INST OF HLTH INTESTINAL MICROECOLOGY INFLAMMATORY MARKERS AND NECROTIZINGENTEROCOLITIS
NOVAK M A AMER ACAD OF PEDIATRICS YOUNG ADULT CANCER SURVIVORS IN TRANSITION
RADONOVICH K NATL INST OF HLTH DEVELOPING A NOVEL TREATMENT FOR RESTRICTED INFLEXIBLE BEHAVIOR
RADONOVICH K US DEPT OF DEFENSE ABNORMAL VESTIBULO-OCULAR REFLEXES IN AUTISM: A POTENTIAL   ENDOPHENOTYPE
RIVERS A E NATL INST OF HLTH DEVELOPMENT OF AAV VECTORS FOR THE PHENOTYPIC CORRECTION OF SICKLE CELL DISEASE
RIVERS A EMMAUS MEDICAL …L-GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA AND SICKLE BETA 0 – THALASSEMIA
ROTH J AGCY FOR HLTH CARE ADMN FLORIDA MEDICAID MATERNAL AND CHILD HEALTH STATUS INDICATORS
ROTH J AGCY FOR HLTH CARE ADMN REGIONAL PERINATAL INTENSIVE CARE CENTERS (RPICC) DATA SYSTEM
ROTH J FL CLINICAL PRACTICE ASSO INPROVING INTIMATE PARTNER VIOLENCE SCREENING AND REFERRAL IN THE ED
SAIDI A AGCY HEALTHCARE RES & QUALITY COMPARATIVE SAFETY AND EFFECTIVENESS OF STIMULANTS          IN MEDICAID YOUTH WITH ADHD.
SAIDI A S AGCY HEALTHCARE RES & QUALITY COMPARATIVE SAFETY AND EFFECTIVENESS OF STIMULANTS          IN MEDICAID YOUTH WITH ADHD.
SCHATZ D A ELI LILLY AND CO THE GLOBAL HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY    (HYPOCCS): ID #B9R-MC-GDGA
SCHATZ D A GEORGIA HLTH SCIENCES UNIV CONSORTIUM FOR IDENTIFICATION OF ENVIRONMENTAL TRIGGERS
SCHATZ D A REIMBURSEMENT PAYMENTS FOR PHYSICIANS EFFORTS
SCHATZ D A JAEB CTR FOR HLTH RES T1D EXCHANGE TYPE 1 DIABETED NETWORK
SCHATZ D A JUVENILE DIABETES FOU CORD BLOOD THERAPIES FOR TYPE 1 DIABETES                    PROJECT ONE
SCHATZ D A NATL INST OF HLTH IMMUNE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES
SCHATZ D A  NATL INST OF HLTH TRIALNET: UNIVERSITY OF FLORIDA CLINICAL CENTER AND NETWORK
SCHATZ D A TKL RESEARCH A PHASE III 3 ARM RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED MULTICENTER STUDY TO INVESTIGATE THE IMPACT OF DIAMYD……
SCHATZ D A UNIV OF SOUTH FLORIDA TRIALNET AFFILATE SERVICES
SCHULER P CYSTIC FIBROSIS FOU CYSTIC FIBROSIS FOUNDATION CARE CENTER
SHAFI N UNIV OF UTAH EXPANSION AND DIFFERENTIATION OF NEURAL STEM CELLS AFTER    TRANSPLANTATION IN SPINAL CORD INJURY
SILVERSTEIN J H GENENTECH INC GENENTECH NATIONAL COOPERATIVE GROWTH STUDY (NCGS)
SILVERSTEIN J H GEORGE WASHINGTON UNIV TODAY GENETICS STUDY
SILVERSTEIN J H NATL INST OF HLTH EXTENSION FAMILY LIFESTYLE INTERVENTION PROJECT
SILVERSTEIN J H NOVO NORDISK PHARMACEUTICALS NORDITROPIN NATIONAL REGISTRY AGREEMENT
SILVERSTEIN J H PFIZER INC A MULTI-CENTER, OPEN-LABE, SINGLE-ARM STUDY ASSESSING DYAD (SUBJECT AND CAREGIVER) PERCEPTION F CONVENNIENCE AND PREFERE
SILVERSTEIN J H  PFIZER INC A THREE YEAR PROSPECTIVE OPEN-LABEL STUDY TO EVALUATE CLINICEFFICACY SAFETY AND TOLERABILITY OF ATORVASTATIN IN CHILDREN
SILVERSTEIN J H  PFIZER INC PFIZER INTERNATIONAL GROWTH STUDY
SLAYTON W B CHILDRENS ONCOLOGY GROUP COG CHAIRS GRANT
SLAYTON W B NATL CHILDHOOD CANCER FOU CHILDRENS ONCOLOGY GROUP CHAIRS GRANT
SLAYTON W B  NATL CHILDHOOD CANCER FOU ST. BALDRICKS FOUNDATION TO SUPPORT PEDIATRIC CANCER        RESEARCH
SLINGER-CONSTANT A J FL DEPT OF EDUCATION MULTIDISCIPLINARY DIAGNOSTIC AND TRAINING PROGRAM
SMITH A A ALEX’S LEMONADE STAND FDTN EXPANDING HOPE: INNOVATIVE THERAPY AT SHANDS CHILDREN’S     HOSPITAL.
NATL CHILDHOOD CANCER FOU CHILDRENS ONCOLOGY GROUP CHAIRS GRANT
SRIVASTAVA A BAYER GROUP NOVEL AAV VECTORS AND STRATEGIES FOR THE POTENTIAL GENE     THERAPY OF HEMOPHILIA A
SRIVASTAVA A NATL INST OF HLTH NEXT GENERATION OF RECOMBINANT AAV SEROTYPE VECTORS FOR GENETHERAPY
SRIVASTAVA A  NATL INST OF HLTH RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES     PROJ 1
SULLIVAN S E AMER ACAD OF PEDIATRICS 2010 OBESITY PREVENTION RESIDENCY TRAINING PROGRAM
SULLIVAN S E PROLACTA BIOSCIENCE A RANDOMIZED STUDY OF HUMAN MILK-BASED VERSUS BOVIN-BASED NUTRITION FOR VERY LOW BIRTH WEIGHT PRE-TERM INFANTS
TEN I S PNEUMA PHARMACEUTICALS CALFACTANT THERAPY FOR DIRECT ACUTE RESPIRATORY DISTRESS SYNDROME & DIRECT ACUTE LUNG INJURY IN ADULTS AND CHILDREN
THOMPSON L A UNIV OF NORTH CAROLINA PROMIS PEDIATRICS: LONGITUDINAL VALIDATION AND LINKING PEDIATRIC AND ADULT ITEM B
UDASSI S AMER ACAD OF PEDIATRICS ALTERNATIVE CHEST COMPRESSION AND DECOMPRESSION TECHNIQUES  IN PIGLET MODEL OF CARDIAC ARREST
WAGNER M H HLTH RESOURCES & SERVICES ADM PEDIATRIC PULMONARY CENTER
WEISS M D CBR SYSTEMS HYPOXIC-ISCHEMIC ENCEPHALOPATHY (HIE) STEM CELL THERAPY
WILLIAMS C A GENZYME CORP EDUCATION ACTIVITIES ON THE TOPIC OF LYSOSOMAL STORAGE DISORDERS (LSDS).
ZOLOTUKHIN S JOHNS HOPKINS UNIV GENE AND PHARM THERAPIES FOR CYSTIC FIB-CORE A (VC)
ZOLOTUKHIN S NATL INST OF HLTH CORE B:  GENE THERAPY USING VIRAL VECTOR FOR LUNG AND       CARDIOVASCULAR DISEASE
ZOLOTUKHIN S NATL INST OF HLTH NEXT GENERATION OF RECOMBINANT AAV SEROTYPE VECTORS FOR GENETHERAPY
ZOLOTUKHIN S NATL INST OF HLTH STRUCTURAL STUDIES OF AAV CAPSIDS AND THEIR GLYCAN RECEPTOR INTERACTIONS
ZORI R T BIOMARIN PHARMACEUTICAL A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE SAFETY & THERAPEUTIC EFFECTS OF SAPROPTERIN……..
ZORI R T BIOMARIN PHARMACEUTICAL A PHASE 2, OPEN-LABEL STUDY TO EVALUATE THE SAFETY,         TOLERABILITY,AND EFFICACY OF SUBCUTANEOUS DOSE LEVELS OF RAV
ZORI R T BIOMARIN PHARMACEUTICAL PKUDOS – PKU DEMOGRAPHICS, OUTCOMES, AND SAFETY REGISTRY
ZORI R T HAYWARD FOU, JOHN & WINIFRED GENETIC COUNSELING GRADUATE PROGRAM FEASIBILITY STUDY
ZORI R T  HAYWARD FOU, JOHN & WINIFRED HAYWARD FOUNDATION GRANT
ZORI R T HYPERION THERAPEUTICS A PHASE 3: OPEN-LABEL STUDY OF THE SAFETY OF HPN-100 FOR THELONG TERM TREATMENT OF UREA CYCLE DISORDERS (TREAT UCD)…..